Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Obstetrics and Gynecology International|February 28, 2015
Mode of vaginal delivery: a modifiable intrapartum risk factor for obstetric anal sphincter injuryMarta Simó González, Oriol Porta Roda, Josep Perelló Capó, et al.Women'S Health Reports (New Rochelle, N.Y.)|October 27, 2025
Usefulness of the Heavy Menstrual Bleeding Diagnostic Tools SAMANTA Questionnaire and Heavy Menstrual Bleeding-Visual Analog Scale Tool for Iron Deficiency Screening: An Exploratory Analysis from the COLIBRI StudyJosep Perelló-Capó, Josep Estadella-Tarriel, Ignasi Gich-Saladich, et al.Reproductive Biomedicine Online|July 26, 2017
Weight decrease improves live birth rates in obese women undergoing IVF: a pilot studyJuan J Espinós, Ana Polo, Juan Sánchez-Hernández, et al.Acta Cytologica|June 1, 2007
Effectiveness of liquid-based cytology and papanicolaou tests in a low risk populationEnrique Lerma, Maria Jesús Quintana, Manel Quilez, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 23, 2023
NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 studySophia von Stockum, Kerstin Becker, Anja Bauerfeind, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 8, 2023
NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 studySophia von Stockum, Anja Bauerfeind, Kerstin Becker, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 2018
Epidemiology of uterine myomas and clinical practice in Spain: An observational studyJavier Monleón, María Luisa Cañete, Virginia Caballero, et al.Medicina Clinica|November 6, 2019
Validation of the Spanish version of the Uterine Fibroid Symptom and Quality of Life (UFS-QoL) questionnaire in women with uterine myomatosisJoaquim Calaf, Santiago Palacios, Ignacio Cristóbal, et al.Contraception|January 17, 2024
Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trialJosep Perelló-Capó, Josep Estadella-Tarriel, Ignasi Gich-Saladich, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 24, 2018
What do TSECs provide in the menopausal hormone therapy?Placido Llaneza, Joaquim Calaf, Ana Rosa Jurado, et al.Pageof 5